Literature DB >> 23916320

Clinical and pharmacological aspects of bath salt use: a review of the literature and case reports.

Karen Miotto1, Joan Striebel, Arthur K Cho, Christine Wang.   

Abstract

Bath salts are designer drugs with stimulant properties that are a growing medical and psychiatric concern due to their widespread availability and use. Although the chemical compounds in the mixtures referred to as "bath salts" vary, many are derivatives of cathinone, a monoamine alkaloid. Cathinones have an affinity for dopamine, serotonin, and norepinephrine synapses in the brain. Because of the strong selection for these neurotransmitters, these drugs induce stimulating effects similar to those of methamphetamines, cocaine, and 3,4-methylenedioxy-N-methylamphetamine (MDMA). Much of the emerging information about bath salts is from emergency department evaluation and treatment of severe medical and neuropsychiatric adverse outcomes. This review consists of a compilation of case reports and describes the emergent literature that illustrates the chemical composition of bath salts, patterns of use, administration methods, medical and neuropsychiatric effects, and treatments of patients with bath salt toxicity.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Bath salts; Cathinone; Hallucinations; Psychosis; Stimulant; Tachycardic

Mesh:

Substances:

Year:  2013        PMID: 23916320     DOI: 10.1016/j.drugalcdep.2013.06.016

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  34 in total

1.  Novel psychoactive substance use by US adolescents: Characteristics associated with use of synthetic cannabinoids and synthetic cathinones.

Authors:  Megan E Patrick; Patrick M O'Malley; Deborah D Kloska; John E Schulenberg; Lloyd D Johnston; Richard A Miech; Jerald G Bachman
Journal:  Drug Alcohol Rev       Date:  2015-12-29

2.  Synthetic and Other Drug Use among High School Students: The Role of Perceived Prevalence, Access, and Harms.

Authors:  Katrina J Debnam; Shonali Saha; Catherine P Bradshaw
Journal:  Subst Use Misuse       Date:  2018-04-06       Impact factor: 2.164

3.  Investigation of "bath salts" use patterns within an online sample of users in the United States.

Authors:  Patrick S Johnson; Matthew W Johnson
Journal:  J Psychoactive Drugs       Date:  2014 Nov-Dec

4.  Synthetic cathinones and their rewarding and reinforcing effects in rodents.

Authors:  Lucas R Watterson; M Foster Olive
Journal:  Adv Neurosci (Hindawi)       Date:  2014-06-04

Review 5.  Toxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literature.

Authors:  Joji Suzuki; Michael A Dekker; Erin S Valenti; Fabiola A Arbelo Cruz; Ady M Correa; Justin L Poklis; Alphonse Poklis
Journal:  Psychosomatics       Date:  2014-11-06       Impact factor: 2.386

6.  Investigations of the genotoxic properties of two synthetic cathinones (3-MMC, 4-MEC) which are used as psychoactive drugs.

Authors:  Halh Al-Serori; Franziska Ferk; Verena Angerer; Miroslav Mišík; Armen Nersesyan; Tahereh Setayesh; Volker Auwärter; Elisabeth Haslinger; Wolfgang Huber; Siegfried Knasmüller
Journal:  Toxicol Res (Camb)       Date:  2016-07-22       Impact factor: 3.524

Review 7.  Stimulant Use in Pregnancy: An Under-recognized Epidemic Among Pregnant Women.

Authors:  Marcela C Smid; Torri D Metz; Adam J Gordon
Journal:  Clin Obstet Gynecol       Date:  2019-03       Impact factor: 2.190

8.  Problem-solving deficits in methcathinone use disorder.

Authors:  Hang-Bin Zhang; Di Zhao; Yu-Ping Liu; Li-Xun Wang; Bo Yang; Ti-Fei Yuan
Journal:  Psychopharmacology (Berl)       Date:  2021-07-22       Impact factor: 4.530

9.  Synthetic Cathinones: A Brief Overview of Overviews with Applications to the Forensic Sciences.

Authors:  Richard A Glennon; Małgorzata Dukat
Journal:  Ann Forensic Res Anal       Date:  2017-03-21

Review 10.  Neuropathology of substance use disorders.

Authors:  Jean Lud Cadet; Veronica Bisagno; Christopher Mark Milroy
Journal:  Acta Neuropathol       Date:  2013-11-29       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.